Augmentin XR Trademark Details

Augmentin Xr was registered on Tuesday, May 11, 2004 and is currently owned by Glaxosmithkline LLC under the registration number 2841466 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 9 years ago on Monday, May 5, 2014, according to the United State Patent & Trademark Office
Word Mark Augmentin Xr
Status Alive Registered 800 — Registered and Renewed

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation
Serial Number 78071198
Registration Number 2841466
Status Date Monday, May 5, 2014
Filing Date Monday, May 5, 2014
Registration Date Tuesday, May 11, 2004
Attorney Christopher M. Hanes
Domestic Representative Diane K. Fry

Correspondent

Christopher M. Hanes
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park NC 27709

Case File Statements

Disclaimer with Predetermined Text "Xr"
Goods & Services Antibiotic preparations

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, July 5, 2001
First Use Anywhere Monday, September 30, 2002
First Use In Commerce Monday, September 30, 2002
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.